Skip to main content

DENGVAXIA dengue tetravalent vaccine (live, attenuated), powder and diluent for suspension for injection (2023-24)

Product name
DENGVAXIA dengue tetravalent vaccine (live, attenuated), powder and diluent for suspension for injection
Sponsor name
Sanofi-Aventis Australia Pty Ltd
Year Range
2023-24

Help us improve the Therapeutic Goods Administration site